State Street Corp Avidity Biosciences, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 4,602,191 shares of RNA stock, worth $148 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,602,191

Previous 4,706,106 2.21%

Holding current value

$148 Million

Previous $216 Million 38.08%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$29.08 - $52.5 $3.02 Million - $5.46 Million	-103,915 Reduced 2.21%	4,602,191 $134 Million
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $51.6 Million - $66.7 Million	1,386,087 Added 41.75%	4,706,106 $216 Million
Q2 2024 Aug 14, 2024	SELL	$22.73 - $40.85 $3.22 Million - $5.79 Million	-141,803 Reduced 4.1%	3,320,019 $136 Million
Q1 2024 May 15, 2024	BUY	$9.16 - $25.52 $215,205 - $599,566	23,494 Added 0.68%	3,461,822 $88.3 Million
Q4 2023 Feb 14, 2024	SELL	$4.87 - $9.37 $3.52 Million - $6.76 Million	-721,964 Reduced 17.35%	3,438,328 $31.1 Million
Q3 2023 Nov 14, 2023	SELL	$6.3 - $11.35 $12.8 Million - $23 Million	-2,029,301 Reduced 32.79%	4,160,292 $26.5 Million
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $19.2 Million - $31.4 Million	1,812,533 Added 41.41%	6,189,593 $68.6 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $12.4 Million - $20.7 Million	806,933 Added 22.6%	4,377,060 $67.2 Million
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $18.2 Million - $41 Million	1,809,796 Added 102.81%	3,570,127 $79.2 Million
Q3 2022 Nov 15, 2022	SELL	$15.46 - $23.43 $1.2 Million - $1.81 Million	-77,344 Reduced 4.21%	1,760,331 $28.7 Million
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $2.19 Million - $4.01 Million	195,808 Added 11.93%	1,837,675 $26.7 Million
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $3.47 Million - $5.81 Million	244,464 Added 17.49%	1,641,867 $30.3 Million
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $644,660 - $905,684	-31,601 Reduced 2.21%	1,397,403 $33.2 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $1.56 Million - $2.17 Million	85,886 Added 6.39%	1,429,004 $35.2 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $108,989 - $162,539	-5,555 Reduced 0.41%	1,343,118 $33.2 Million
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $13.5 Million - $18.8 Million	667,679 Added 98.04%	1,348,673 $29.4 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $10.8 Million - $15.3 Million	436,557 Added 178.6%	680,994 $17.4 Million
Q3 2020 Nov 10, 2020	BUY	$23.35 - $35.94 $5.71 Million - $8.79 Million	244,437 New	244,437 $6.88 Million

Others Institutions Holding RNA

# of Institutions

258

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.67B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Avidity Biosciences, Inc. Transaction History